A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
Clinical trial NCT03052205 · COMPLETED
Trial details
- NCT number
- NCT03052205
- Sponsor
- Idera Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-09
- Primary completion
- 2019-07-24
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.